L-Tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-prolyl-L-valyl-L-lysyl-L-arginyl-L-arginyl-L-leucyl-L-α-aspartyl-L-leucine

Request For Quotation
L-Tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-prolyl-L-valyl-L-lysyl-L-arginyl-L-arginyl-L-leucyl-L-α-aspartyl-L-leucine Basic information
Product Name:L-Tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-prolyl-L-valyl-L-lysyl-L-arginyl-L-arginyl-L-leucyl-L-α-aspartyl-L-leucine
Synonyms:L-Tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-prolyl-L-valyl-L-lysyl-L-arginyl-L-arginyl-L-leucyl-L-α-aspartyl-L-leucine
CAS:237392-85-7
MF:C110H200N48O25
MW:2595.08
EINECS:
Product Categories:
Mol File:237392-85-7.mol
L-Tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-prolyl-L-valyl-L-lysyl-L-arginyl-L-arginyl-L-leucyl-L-α-aspartyl-L-leucine Structure
L-Tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-prolyl-L-valyl-L-lysyl-L-arginyl-L-arginyl-L-leucyl-L-α-aspartyl-L-leucine Chemical Properties
density 1.50±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
Safety Information
MSDS Information
L-Tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-prolyl-L-valyl-L-lysyl-L-arginyl-L-arginyl-L-leucyl-L-α-aspartyl-L-leucine Usage And Synthesis
UsesCdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1].
References[1] Chen YN, et al. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4325-9. DOI:10.1073/pnas.96.8.4325
L-Tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-prolyl-L-valyl-L-lysyl-L-arginyl-L-arginyl-L-leucyl-L-α-aspartyl-L-leucine Preparation Products And Raw materials
Tag:L-Tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycyl-L-prolyl-L-valyl-L-lysyl-L-arginyl-L-arginyl-L-leucyl-L-α-aspartyl-L-leucine(237392-85-7) Related Product Information
CDK12-CCNK HETERODIMER Protein, HUMAN (SF9) CDK3-CCNE1 HETERODIMER Protein, HUMAN (SF9) THZ1 OTS964 hydrochloride GSK-3326595 DRB